ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

KNE Kane Biotech Inc

0.14
0.01 (7.69%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kane Biotech Inc KNE TSX Venture Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.01 7.69% 0.14 08:37:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.14 0.14 0.14 0.14 0.13
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/5/202415:15GLOBEKane Biotech Announces First Quarter 2024 Financial Results
16/5/202407:00GLOBEKane Biotech to Release First Quarter 2024 Financial Results..
15/5/202407:00GLOBEKane Biotech Expands its Wound Care Portfolio with Patented..
16/4/202408:15GLOBEKane Biotech to Host Investor Webinar
15/4/202410:07APSDual Listed Biotech Firm Achieves Sale of Animal Health..
15/4/202408:15GLOBEKane Biotech Announces Closing of the Sale of STEM Animal..
11/4/202409:03PRNCAL'Organisme canadien de réglementation des investissements..
11/4/202409:00PRNCACanadian Investment Regulatory Organization Trade Resumption..
11/4/202408:45GLOBEKane Biotech Announces Agreement in Principle for the Sale..
11/4/202408:07PRNCASuspension de la négociation par l'Organisme canadien de..
11/4/202408:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
26/3/202415:05GLOBEKane Biotech Announces Fourth Quarter and Full Year 2023..
20/3/202407:30GLOBEKane Biotech Extends Exclusivity Period on its Offer for its..
19/3/202415:10GLOBEKane Biotech to Release Fourth Quarter and Full Year 2023..
08/3/202408:00GLOBEKane Biotech Receives Bioscience Association Manitoba..
22/2/202407:00GLOBEDr. Robert Huizinga Elected to the Kane Biotech Board and..
31/1/202407:30GLOBEKane Biotech Files New Patent on revyve™ Antimicrobial Wound..
25/1/202411:03GLOBEKane Biotech to Present its revyve™ Antimicrobial Wound Gel..
18/1/202415:30GLOBEKane Biotech Announces Special Meeting of Shareholders
29/12/202313:33GLOBEKane Biotech Announces Correction to Press Release
28/12/202315:05GLOBEKane Biotech Announces Amendment to its Credit Facility
20/12/202307:29GLOBEKane Biotech Receives Offer for its Interest in STEM Animal..
28/11/202315:05GLOBEKane Biotech Announces Improved Third Quarter 2023 Financial..
21/11/202306:45GLOBEKane Biotech to Release Third Quarter 2023 Financial Results..
16/11/202312:45GLOBEKane Biotech Strengthens Board with Biotech Executive
02/11/202310:48GLOBEKane Biotech and ProgenaCare Global Launch Newly Rebranded..
25/10/202306:45GLOBEKane Biotech to Exhibit at Symposium on Advanced Wound Care..
12/9/202306:45GLOBEKane Biotech Announces Closing of Fully Subscribed Private..
29/8/202315:29GLOBEKane Biotech Announces Second Quarter 2023 Financial Results
22/8/202306:30GLOBEKane Biotech to Release Second Quarter 2023 Financial..
03/8/202306:45GLOBEKane Biotech Announces Private Placement Offering and..
02/8/202306:30GLOBEKane Biotech Engages Research Capital to Conduct Strategic..
23/6/202316:30GLOBEKane Biotech Announces Issuance of Restricted Share Units